Kura Oncology, Inc. SEC filings KURA

Kura Oncology, Inc. has 806 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (other events). The company's fiscal year ends on December 31.

Kura Oncology, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jun 4, 2026 —
S-8 Employee stock plan registration Nov 4, 2025 —
S-8 Employee stock plan registration Jun 6, 2025 —
S-8 Employee stock plan registration Feb 28, 2025 —
S-8 Employee stock plan registration Jun 7, 2024 —
S-8 Employee stock plan registration Feb 27, 2024 —
424B3 Prospectus Feb 15, 2024 —
S-3 Shelf registration Feb 9, 2024 —
S-3ASR Automatic shelf registration Nov 2, 2023 —
424B5 Prospectus supplement Jun 14, 2023 —
424B5 Prospectus supplement Jun 13, 2023 —
S-8 Employee stock plan registration Jun 2, 2023 —
S-8 Employee stock plan registration Feb 24, 2023 —
424B5 Prospectus supplement Nov 3, 2022 —
S-8 Employee stock plan registration Feb 24, 2022 —
424B5 Prospectus supplement Feb 24, 2022 —
S-8 Employee stock plan registration Feb 24, 2021 —
424B5 Prospectus supplement Dec 9, 2020 —
424B5 Prospectus supplement Dec 7, 2020 —
S-3ASR Automatic shelf registration Dec 7, 2020 —
424B3 Prospectus Aug 19, 2020 —
S-3 Shelf registration Aug 6, 2020 —
424B5 Prospectus supplement May 6, 2020 —
424B5 Prospectus supplement May 5, 2020 —
S-8 Employee stock plan registration Feb 25, 2020 —
424B3 Prospectus Aug 28, 2019 —
S-3/A Filing Aug 21, 2019 —
S-3 Shelf registration Aug 1, 2019 —
424B5 Prospectus supplement Jun 19, 2019 —
424B5 Prospectus supplement Jun 18, 2019 —
S-8 Employee stock plan registration Mar 5, 2019 —
424B5 Prospectus supplement Mar 5, 2019 —
424B3 Prospectus Nov 27, 2018 —
S-3 Shelf registration Nov 5, 2018 —
424B5 Prospectus supplement Jun 28, 2018 —
S-3MEF Filing Jun 27, 2018 —
424B5 Prospectus supplement Jun 27, 2018 —
S-8 Employee stock plan registration Mar 12, 2018 —
424B5 Prospectus supplement Mar 12, 2018 —
424B5 Prospectus supplement Dec 4, 2017 —
424B3 Prospectus Dec 4, 2017 —
S-3/A Filing Nov 28, 2017 —
S-3 Shelf registration Nov 9, 2017 —
424B5 Prospectus supplement Aug 11, 2017 —
424B5 Prospectus supplement Aug 9, 2017 —
S-8 Employee stock plan registration Mar 14, 2017 —
424B5 Prospectus supplement Jan 27, 2017 —
424B3 Prospectus Apr 15, 2016 —
424B3 Prospectus Apr 15, 2016 —
S-3 Shelf registration Apr 5, 2016 —
POS AM Filing Apr 5, 2016 —
424B3 Prospectus Apr 5, 2016 —
S-8 Employee stock plan registration Mar 17, 2016 —
424B3 Prospectus Mar 17, 2016 —
424B3 Prospectus Feb 4, 2016 —
424B3 Prospectus Nov 13, 2015 —
424B4 Prospectus Nov 5, 2015 —
S-1/A Amended registration statement Oct 28, 2015 —
424B3 Prospectus Oct 20, 2015 —
S-1 Registration statement Oct 20, 2015 —
424B3 Prospectus Oct 14, 2015 —
424B3 Prospectus Aug 14, 2015 —
424B3 Prospectus Aug 6, 2015 —
424B3 Prospectus Jul 22, 2015 —
S-1/A Amended registration statement Jul 2, 2015 —
S-1/A Amended registration statement Jun 2, 2015 —
S-8 Employee stock plan registration Apr 17, 2015 —
S-1 Registration statement Apr 17, 2015 —

Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KURA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1422143
Former names
ZETA ACQUISITION CORP III (until Mar 10, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.